PapersFlow Research Brief
Malaria Research and Control
Research Guide
What is Malaria Research and Control?
Malaria Research and Control encompasses scientific studies and interventions targeting the Plasmodium parasites, Anopheles mosquito vectors, antimalarial drug development, vaccine efforts, epidemiology, and strategies to mitigate the global burden of malaria.
The field includes 167,361 works on topics such as genome sequences of malaria parasites, drug resistance, mosquito vectors, vaccine development, epidemiology, and the global burden of the disease. Key advances involve continuous culture of Plasmodium falciparum in human erythrocytes, as shown by Trager and Jensen (1976), and synchronization of erythrocytic stages using sorbitol treatment, per Lambros and Vanderberg (1979). Environmental changes' impact on transmission and new antimalarial drugs are also central areas.
Topic Hierarchy
Research Sub-Topics
Plasmodium falciparum Genomics
Plasmodium falciparum genomics sequences and annotates the malaria parasite genome, identifying genes for virulence and drug resistance. Researchers apply comparative genomics and functional studies to parasite biology.
Artemisinin Resistance Mechanisms
Artemisinin resistance studies genetic mutations like Pfkelch13 and phenotypic survival traits in Southeast Asian strains. Researchers model spread, fitness costs, and combination therapy efficacy.
Anopheles Mosquito Vector Biology
Anopheles mosquito vector biology examines species genetics, behavior, and insecticide resistance for transmission control. Researchers develop genetic drives and paratransgenic approaches.
Malaria Vaccine Development
Malaria vaccine development targets antigens like circumsporozoite protein in RTS,S and next-generation candidates. Researchers optimize adjuvants, transmission-blocking vaccines, and correlates of protection.
Malaria Epidemiology and Modeling
Malaria epidemiology and modeling maps disease burden, transmission dynamics, and intervention impacts using geospatial data. Researchers forecast climate effects and elimination feasibility.
Why It Matters
Malaria control efforts in Africa between 2000 and 2015 substantially reduced Plasmodium falciparum prevalence, with Bhatt et al. (2015) documenting intervention effects across sub-Saharan Africa through modeling epidemiological data. Artemisinin resistance in Plasmodium falciparum, identified by Dondorp et al. (2009) in western Cambodia with slow parasite clearance rates, necessitates urgent containment to preserve treatment efficacy. Recent news highlights ganaplacide–lumefantrine curing 97.4% of participants in clinical trials, outperforming existing treatments at 94%, addressing drug resistance in Africa. Gene-drive-capable mosquitoes suppressed patient-derived malaria in Tanzania, advancing vector control. Since 2000, global efforts averted 2.3 billion cases and 14 million deaths.
Reading Guide
Where to Start
'Human Malaria Parasites in Continuous Culture' by Trager and Jensen (1976) first, as it provides the foundational technique for maintaining Plasmodium falciparum in vitro, essential for all subsequent lab-based malaria research.
Key Papers Explained
Trager and Jensen (1976) enabled continuous culture in 'Human Malaria Parasites in Continuous Culture', which Lambros and Vanderberg (1979) built upon for synchronization in 'Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture' using sorbitol. Gardner et al. (2002) leveraged these tools for the full genome sequence in 'Genome sequence of the human malaria parasite Plasmodium falciparum'. Desjardins et al. (1979) then standardized drug testing in 'Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique'. Dondorp et al. (2009) applied such methods to identify artemisinin resistance in 'Artemisinin Resistance in Plasmodium falciparum Malaria', while Bhatt et al. (2015) modeled control impacts in 'The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015'.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Gene-drive-capable mosquitoes suppressed patient-derived malaria in Tanzania per recent preprint (2025). Ganaplacide–lumefantrine achieved 97.4% cure rates in trials against resistance (2025 news). Cluster randomized trials evaluate vector suppression designs (2025 preprint). Model reduction aids transmission analysis (2025 preprint). Tools like RAMP propagate uncertainty in policy analytics.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The global distribution and burden of dengue | 2013 | Nature | 9.8K | ✓ |
| 2 | Human Malaria Parasites in Continuous Culture | 1976 | Science | 7.9K | ✕ |
| 3 | Genome sequence of the human malaria parasite Plasmodium falci... | 2002 | Nature | 4.4K | ✓ |
| 4 | Synchronization of Plasmodium falciparum Erythrocytic Stages i... | 1979 | Journal of Parasitology | 3.7K | ✓ |
| 5 | Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria | 2009 | New England Journal of... | 3.4K | ✓ |
| 6 | The effect of malaria control on Plasmodium falciparum in Afri... | 2015 | Nature | 3.3K | ✓ |
| 7 | Production of the antimalarial drug precursor artemisinic acid... | 2006 | Nature | 2.8K | ✕ |
| 8 | The global distribution of clinical episodes of Plasmodium fal... | 2005 | Nature | 2.7K | ✓ |
| 9 | Zika Virus (I). Isolations and serological specificity | 1952 | Transactions of the Ro... | 2.7K | ✕ |
| 10 | Quantitative assessment of antimalarial activity in vitro by a... | 1979 | Antimicrobial Agents a... | 2.5K | ✓ |
In the News
Gene-drive-capable mosquitoes suppress patient-derived malaria in Tanzania
drive technology a critical step closer to application, providing a locally tailored and powerful tool for malaria eradication through the targeted dissemination of beneficial genetic traits in wil...
First new type of malaria treatment in decades shows promise against drug resistance
Promising results from a new malaria drug offer hope against emerging drug resistance in Africa. In a clinical trial, ganaplacide–lumefantrine (GanLum) cured 97.4% of participants, outperforming an...
How a Malaria-Fighting Breakthrough Provides Lasting Protection
The study was funded by the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health (NIH). It appears Aug. 26 in *eBioMedicine* , which is publishe...
New tools saved a million lives from malaria last year but ...
Venture. ““The development of the first non-artemisinin combination therapy, Ganaplacide––Lumefantrine,is proof that this is possible, and it represents the beginning of a new chapter in malaria re...
Malaria: Drug resistance and underfunding threaten progress ...
* Progress since 2000: Malaria control efforts have averted 2.3 billion cases and 14 million deaths globally.
Code & Tools
Policy advice should be robust to uncertainty. Robust Analytics for Malaria Policy (RAMP) was developed as a bespoke inferential system for malaria...
Repository with installation scripts and environment definitions for conda and texlive, for standardising environments across the MalariaGEN resour...
OutbreakLens is a comprehensive healthcare platform that combines cutting-edge machine learning with epidemiological expertise to revolutionize mal...
PGEforge is a community-driven platform designed to simplify*Plasmodium*genomic data analysis. The process of analyzing genomic data often involves...
Malaria analytics is the systematic analysis of data for decision support or to guide malaria policies. Simulation-based malaria analytics is malar...
Recent Preprints
Gene-drive-capable mosquitoes suppress patient-derived malaria in Tanzania
Gene drive technology presents a transformative approach to combatting malaria by introducing genetic modifications into wild mosquito populations to reduce their vectorial capacity. Although effec...
Model reduction and analysis: A case study of a malaria ...
analysis, we compare the two models and show that the reduced system exhibits similar transmission characteristics as the full model. Our results demonstrate that the reduced model effectively capt...
New study on cluster randomised controlled trials for ...
In a new study titled “ Requirements for designing cluster randomised control trials to detect suppression of malaria vector ”, our research teams in Burkina Faso and the United Kingdom have invest...
Effectiveness of malaria control interventions in resource- ...
**Introduction:** Malaria remains a key public health encounter in countries with resource limitations, where efforts to control the disease often focus on vector control strategies like insecticid...
Know your enemy: understanding mosquito biology to ...
Over a century has passed since the discovery that the female anopheline mosquito is a vector of malaria, prompting extensive efforts to combat the disease. Vector control remains the primary malar...
Latest Developments
Recent developments in malaria research and control as of February 2026 include the approval and rollout of new malaria vaccines like R21/Matrix-M, supported by Gavi to protect 50 million children between 2026 and 2030 (Sabin Vaccine Institute). Advances in genetic vector control technologies, such as gene-drive mosquitoes, have shown promise, with studies demonstrating their potential to suppress malaria transmission, including in Tanzania (Nature) and through self-limited female-sterile mosquito systems (Nature Communications). Additionally, new treatments targeting drug resistance are under investigation, and climate change impacts on malaria are being modeled to inform future control strategies (Nature, MMV).
Sources
Frequently Asked Questions
What method enabled continuous culture of Plasmodium falciparum?
Trager and Jensen (1976) established continuous culture of Plasmodium falciparum in human erythrocytes at 38°C using RPMI 1640 medium with human serum under 7% CO2 and low oxygen. This breakthrough in 'Human Malaria Parasites in Continuous Culture' allowed sustained parasite propagation from Aotus trivirgatus material. The technique facilitated subsequent research on parasite biology and drug testing.
How is synchronization of Plasmodium falciparum erythrocytic stages achieved in culture?
Lambros and Vanderberg (1979) used 5% D-sorbitol treatment to synchronize cultures, resulting in mainly single asexual ring forms immediately after. Described in 'Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture', this method enables timed studies of parasite development. It supports research on stage-specific interventions.
What characterizes artemisinin resistance in Plasmodium falciparum?
Dondorp et al. (2009) observed reduced in vivo susceptibility to artesunate in western Cambodia compared to northwestern Thailand, marked by slow parasite clearance without in vitro changes. Reported in 'Artemisinin Resistance in Plasmodium falciparum Malaria', this requires urgent containment measures. It threatens artemisinin-based therapies globally.
What was the impact of malaria control on Plasmodium falciparum in Africa from 2000 to 2015?
Bhatt et al. (2015) quantified unprecedented intervention coverage leading to reduced prevalence across sub-Saharan Africa in 'The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015'. Their modeling assessed effects amid varied epidemiology. Findings inform future control planning.
How was the Plasmodium falciparum genome sequenced?
Gardner et al. (2002) completed the genome sequence of the human malaria parasite Plasmodium falciparum, detailed in 'Genome sequence of the human malaria parasite Plasmodium falciparum'. This resource advanced understanding of parasite biology, drug targets, and resistance mechanisms. It enabled genomic epidemiology studies.
What in vitro technique assesses antimalarial activity?
Desjardins et al. (1979) developed a semiautomated microdilution method using microtitration plates for serial dilutions against cultured Plasmodium falciparum in 'Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique'. It measures activity rapidly against intraerythrocytic forms. The approach standardized drug screening.
Open Research Questions
- ? How can gene drive technologies be deployed safely in wild Anopheles populations to suppress malaria transmission, as tested in Tanzania?
- ? What minimal model structures accurately capture malaria transmission dynamics for efficient policy evaluation?
- ? What trial designs optimize cluster randomized controlled trials to detect malaria vector suppression?
- ? How do integrated interventions like ITNs and IRS perform in resource-limited settings against persistent malaria burden?
- ? Which mosquito biological traits can be targeted to enhance vector control beyond current 65% case reduction since 2000?
Recent Trends
Gene-drive-capable mosquitoes demonstrated suppression of patient-derived malaria in Tanzania (preprint, 2025-12-10).
Ganaplacide–lumefantrine cured 97.4% of trial participants, exceeding 94% for existing treatments (news, 2025-11-12).
Control efforts averted 2.3 billion cases and 14 million deaths since 2000 (news, 2025-12-04).
New preprints address cluster trials for vector suppression , model reduction for transmission (2025-08-26), and integrated interventions in resource-limited areas (2025-09-16).
2025-11-05Vector control accounted for 65% case reduction from 2000-2015 (recent preprint).
Research Malaria Research and Control with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Malaria Research and Control with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers